Enclomiphene and drug testing: what athletes need to know

Last updated 2026-07-27

Is enclomiphene banned in sports drug testing?

Yes. Enclomiphene falls under Section S4 of the World Anti-Doping Agency's Prohibited List, the category covering "Hormone and Metabolic Modulators." This section explicitly names "anti-estrogenic substances" including "aromatase inhibitors," "selective estrogen receptor modulators (SERMs) including but not limited to raloxifene, tamoxifen, toremifene," and "other anti-estrogenic substances including but not limited to clomifene, cyclofenil, fulvestrant" ^[1]. Enclomiphene is the active trans-isomer of clomiphene (brand name Clomid), so it falls squarely inside this SERM/anti-estrogen category even where it isn't spelled out by its own name. The S4 category is banned at all times, both in competition and out of competition ^[1]. That's a different tier than substances only prohibited on competition day. It means an athlete subject to testing can't take enclomiphene during an off-season "bridge" or a PCT-style protocol and assume it's fine because no meet is coming up. Whereabouts testing and out-of-competition sample collection exist specifically to catch use during training blocks. WADA's rationale for banning anti-estrogens isn't about enclomiphene raising testosterone directly (it does that indirectly, by blocking estrogen feedback at the hypothalamus). It's that these drugs are used to manage the estrogenic side effects of anabolic steroid cycles and to restart natural testosterone production after a cycle, which makes them a marker for, and enabler of, steroid use. A masking or restart agent gets banned right alongside the drug it supports.

Will enclomiphene show up on a drug test?

Yes, if the lab is looking for it. Anti-doping labs accredited by WADA use liquid chromatography-mass spectrometry (LC-MS/MS) methods that can detect clomiphene, enclomiphene, and their metabolites in urine at low nanogram-per-milliliter concentrations, similar to how they screen for other S4 anti-estrogens like tamoxifen. This isn't experimental science. Clomiphene detection has been part of standard anti-doping method development for years because it's a known post-cycle therapy drug. The practical detection window depends on dose, duration of use, and individual metabolism, and there's no single published number you can rely on as "safe." Enclomiphene itself has a long elimination half-life, commonly cited in the 10-day range based on pharmacokinetic data from the clomiphene isomer studies, and its metabolites can persist longer than the parent compound ^[2]. That means detection windows plausibly extend well past a month for people using it regularly, not days. If you're a tested athlete, don't do the math on "how long until I'm clear." The honest answer is nobody outside an accredited anti-doping lab has published a validated detection window for enclomiphene specifically, and guessing wrong ends a season.

What is enclomiphene, and how is it different from clomiphene or TRT?

Clomiphene citrate (Clomid) is actually a mixture of two isomers: enclomiphene (the trans-isomer) and zuclomiphene (the cis-isomer). Enclomiphene is the isomer that does most of the anti-estrogen work at the hypothalamus, blocking estrogen receptors there so the brain thinks estrogen is low and ramps up GnRH, then LH and FSH, which in turn drives the testes to produce more testosterone and continue sperm production. Zuclomiphene has a much longer half-life and weaker estrogen-blocking activity, and some clinicians believe it contributes more side effects than benefit. Enclomiphene as a standalone product went through clinical development under the name Androxal for secondary hypogonadism, but the program did not reach FDA approval; the drug is not FDA-approved as a standalone product. What's sold today is compounded enclomiphene, prepared by a compounding pharmacy under a prescription, not a commercially manufactured, FDA-approved drug product. That distinction matters for anyone comparing it to prescription testosterone or to approved clomiphene citrate tablets (which are FDA-approved, but for female infertility, not for men). Compared with exogenous testosterone replacement therapy (injectable, gel, or pellet TRT), the mechanism difference is the whole story. TRT delivers testosterone from outside the body, which shuts down the hypothalamic-pituitary-gonadal (HPG) axis via negative feedback, suppressing LH, FSH, and intratesticular testosterone. That suppression is well documented to reduce sperm production and can shrink testicular volume with sustained use. Enclomiphene instead works upstream, stimulating the body's own LH and FSH output, which is why it tends to preserve fertility and testicular size where TRT does not. For men who want the fertility-preservation angle, that mechanism is worth understanding in more depth: see Enclomiphene Direct dosage for how protocols are typically structured around that goal.

Does enclomiphene raise testosterone the same way anabolic steroids do?

No, and this is the point anti-doping rules don't fully credit in casual conversation, even though the ban stands regardless. Anabolic-androgenic steroids add exogenous androgen to the body. Enclomiphene adds nothing directly, it blocks estrogen receptor feedback at the hypothalamus, which increases the body's own gonadotropin-releasing hormone (GnRH), then LH and FSH, then endogenous testicular testosterone production. That's a meaningfully different pharmacological action than injecting testosterone, and it's also different from something like clomiphene's historical off-label use to restart natural production after a steroid cycle ends. But WADA's Prohibited List doesn't distinguish "used to raise your own testosterone" from "used to manage a steroid cycle." Both land in S4 because both interfere with the same estrogen-feedback pathway that anabolic steroid users manipulate. The rule targets the mechanism and the substance class, not the athlete's stated intent.

Can I get a therapeutic use exemption (TUE) for enclomiphene?

In theory, WADA's TUE process exists for exactly this kind of situation: a substance on the Prohibited List that an athlete needs for a legitimate diagnosed medical condition. WADA's International Standard for Therapeutic Use Exemptions requires that the athlete have a clear medical condition requiring the treatment, that no reasonable permitted alternative exists, and that the substance not produce additional performance enhancement beyond what returning to normal health would provide ^[3]. In practice, this is a hard case to win for a healthy competitive athlete. Enclomiphene's usual off-label use is secondary hypogonadism from things like prior anabolic steroid use, or as a TRT alternative in men who want to preserve fertility. A TUE panel is going to scrutinize whether the underlying low testosterone is a genuine, independently diagnosed medical condition, backed by lab work, symptoms, and a treating physician's records, rather than a workaround. If an athlete's low T traces back to past steroid use, that history itself becomes a serious complication in a TUE application. This isn't a form you fill out casually. It requires real endocrinology documentation, and even then, approval isn't guaranteed and the exemption process operates on the sporting organization's own IST-aligned rules, which vary somewhat between USADA, WADA-affiliated federations, and other testing bodies.

What sanctions do athletes actually get for testing positive on a SERM like enclomiphene?

Under the World Anti-Doping Code, a first anti-doping rule violation involving a non-specified substance (and S4 hormone modulators are generally treated as non-specified, meaning higher scrutiny) typically carries a four-year period of ineligibility, unless the athlete can establish the violation was not intentional, in which case the period can be reduced, potentially to as low as no suspension in genuinely exceptional no-fault cases, or more commonly down to a shorter term depending on the facts ^[4]. These are Code-level default sanctions; actual outcomes depend heavily on case-specific findings by the hearing panel. USADA has published numerous sanction decisions involving clomiphene and other S4 anti-estrogens over the years, generally in the multi-year range, which is a useful reality check against any assumption that a SERM violation is treated as minor compared to steroids themselves. The two are often part of the same violation set, because clomiphene is frequently detected alongside anabolic steroid metabolites in the same sample.

Do college and pro sports drug testing programs test for enclomiphene too?

Most major U.S. sports drug testing programs model their prohibited lists on, or directly incorporate, WADA's S4 category, so anti-estrogens including clomiphene-class SERMs are generally banned across NCAA testing, Olympic-affiliated sports, and most professional leagues with independent anti-doping programs. The exact banned-substance list, testing frequency, and penalty structure differ by organization, since NCAA policy, individual pro league collective bargaining agreements, and WADA Code signatories are all separate rulebooks with their own text. The safest working assumption for any athlete under any testing program: if you are tested for banned substances at all, assume anti-estrogens and SERMs are covered, and check your specific sport's current published list before assuming otherwise. Rules get updated annually; WADA republishes its Prohibited List each year, and substance categorization can shift.

Why would someone use enclomiphene instead of testosterone if they're not competing in tested sports?

For men outside of tested competition, the appeal of enclomiphene over injectable TRT comes down to that fertility and testicular-size preservation angle mentioned earlier. Exogenous testosterone suppresses the HPG axis, which lowers LH and FSH and, with it, sperm production; this is well established in the reproductive endocrinology literature as a cause of hypogonadotropic hypogonadism and impaired spermatogenesis during TRT use ^[5]. Men actively trying to conceive, or who simply don't want testicular atrophy and the fertility tradeoff, often look at enclomiphene or clomiphene as an alternative path to raising testosterone. The evidence for enclomiphene's effectiveness at raising testosterone in men with secondary hypogonadism comes primarily from the Androxal clinical trial program, which showed it could raise serum testosterone into the normal range while maintaining LH, FSH, and sperm parameters better than exogenous testosterone comparators in those studies ^[6]. But it's worth being honest about the limits here: this was studied specifically in secondary hypogonadism, the drug never reached FDA approval as a finished product, and men using compounded enclomiphene today are relying on a drug that hasn't gone through the FDA's standard manufacturing, quality, and efficacy review that an approved product would. That doesn't mean it doesn't work. It means the evidence base is real but narrower, and the sourcing question (who's compounding it, under what pharmacy oversight) matters more than it would for an FDA-approved tablet. For men working through dosing questions on a compounded protocol, understanding how to reconstitute Enclomiphene Direct and Enclomiphene Direct cycle length matters more than it would for a standardized manufactured tablet, precisely because compounded formulations vary by pharmacy.

Does enclomiphene preserve fertility better than TRT, and is that guaranteed?

The mechanism strongly favors enclomiphene over exogenous TRT for fertility preservation, and the available clinical data support that direction, but nobody should read this as a guarantee. Because enclomiphene stimulates the body's own LH and FSH rather than shutting the axis down, sperm production is generally maintained or less affected than under testosterone injections, gels, or pellets in the studies that have looked at this question ^[6]. That's the central pharmacological contrast driving interest in enclomiphene as a TRT alternative for men who are also trying to have children or simply don't want testicular shrinkage. But "preserves fertility better than TRT" is not the same claim as "guarantees normal sperm counts" or "guarantees conception." Individual response varies, baseline fertility status varies, and the clinical trial data behind enclomiphene, while favorable, comes from a relatively narrow trial population and hasn't been validated at the scale of, say, decades of testosterone-replacement outcome data. Any man making a fertility-driven decision between TRT and enclomiphene should be working with a physician who can check baseline semen parameters and hormone levels, not assuming a mechanism guarantees an outcome. If pregnancy timing is a real, near-term goal, that's a conversation for a reproductive endocrinologist, not a forum thread.

How is compounded enclomiphene regulated, and does that affect athletes differently?

Compounded drugs occupy a different regulatory lane than FDA-approved medications. Section 503A of the Federal Food, Drug, and Cosmetic Act permits licensed pharmacies to compound medications for individual patients based on a valid prescription, without going through the FDA's new drug approval process, provided they meet specific conditions around ingredient sourcing and non-commercial-scale production ^[7]. That's the legal basis under which compounded enclomiphene is dispensed today, since there is no FDA-approved standalone enclomiphene product on the market. For an athlete, the compounding status doesn't change the anti-doping analysis at all. WADA and USADA don't care whether a banned substance came from an FDA-approved manufacturer, a compounding pharmacy, or anywhere else; what matters is whether the prohibited substance or its metabolites are in the athlete's sample. A prescription, valid or not, doesn't create an exception to the Prohibited List outside the formal TUE process described above. Athletes sometimes assume "my doctor prescribed it legally" is a defense; it is not, absent an approved TUE.

What should a competitive athlete do if they're considering enclomiphene?

Talk to your sport's anti-doping authority before you talk to a compounding pharmacy. If you're subject to USADA, WADA, NCAA, or a pro league's testing program, get a written answer on TUE eligibility for your specific medical situation before starting anything in the S4 category. Retroactive TUEs exist in narrow, defined circumstances but you should never assume one will be granted after the fact. If you're not in tested competition and you're exploring enclomiphene purely as a TRT alternative for the fertility and testicular-size advantages, the conversation is different: it's about finding a legitimate prescriber who orders real baseline labs (total and free testosterone, LH, FSH, estradiol) and follow-up monitoring, not about gaming a drug test. That's the lane where a provider-reviewed path matters most. Enclomiphene Direct connects patients with providers who review labs and prescribe when appropriate, with prescriptions filled through a licensed compounding pharmacy partner, rather than shipping product with no clinical oversight. For dosing specifics once a prescription is in hand, see Enclomiphene Direct dosage calculator, Enclomiphene Direct how to inject (note: enclomiphene is typically an oral capsule, not an injectable, so confirm your specific prescribed form with your provider), and Enclomiphene Direct injection sites if your protocol involves any injectable component alongside it.

Frequently asked questions

Is enclomiphene a banned substance for athletes?

Yes. It falls under WADA's Section S4, Hormone and Metabolic Modulators, which covers anti-estrogenic substances including SERMs and clomiphene-class drugs. It's banned at all times, in and out of competition, under the current WADA Prohibited List ^[1].

How long does enclomiphene stay in your system for drug testing purposes?

There's no published, validated detection window specific to enclomiphene for anti-doping purposes. Its elimination half-life is commonly cited around 10 days, with metabolites potentially detectable longer, so assume a window measured in weeks to over a month for regular use, not days ^[2].

Can I get a TUE (therapeutic use exemption) for enclomiphene?

It's possible in theory if you have a genuine, independently diagnosed medical condition like documented secondary hypogonadism, but panels scrutinize these applications closely, especially if past steroid use is part of the medical history. Approval isn't guaranteed and must go through your sport's official TUE process before you start using it ^[3].

Is enclomiphene the same as clomiphene (Clomid)?

No, but they're closely related. Clomiphene citrate is a mixture of two isomers, enclomiphene and zuclomiphene. Enclomiphene is the more potent anti-estrogen isomer responsible for most of the testosterone-raising effect; zuclomiphene has a longer half-life and is linked to more side effects with less benefit.

Is enclomiphene FDA-approved?

No. Enclomiphene was studied as a standalone drug under the name Androxal, but that program never reached FDA approval. What's available today is compounded enclomiphene, dispensed by licensed compounding pharmacies under an individual prescription, not an FDA-approved manufactured product.

Does enclomiphene preserve fertility better than testosterone therapy?

The mechanism and available clinical data both point that direction. Enclomiphene stimulates the body's own LH and FSH rather than shutting down the HPG axis, so sperm production and testicular size are generally better preserved than with exogenous TRT. That said, this isn't a guarantee of any specific fertility outcome for an individual ^[6].

What happens if I test positive for enclomiphene as an athlete?

Under the World Anti-Doping Code, S4 substances typically carry a default four-year ineligibility period for a first violation unless the athlete proves the violation wasn't intentional, which can reduce the sanction depending on the specific facts of the case ^[4]. Actual outcomes are decided case by case by a hearing panel.

Does having a prescription protect me from an anti-doping violation?

No. A valid prescription does not create an exception to the WADA Prohibited List. The only formal exception is an approved therapeutic use exemption (TUE) obtained in advance through your sport's anti-doping authority, following WADA's International Standard for TUEs ^[3].

Do NCAA and professional sports test for enclomiphene, or just Olympic athletes?

Most major U.S. testing programs, including NCAA and various professional leagues with independent anti-doping programs, model their banned lists on WADA's categories, so SERMs and anti-estrogens are generally covered. Exact lists and penalties differ by organization, so check your sport's current published policy.

Why do bodybuilders and steroid users take clomiphene or enclomiphene?

Historically, as post-cycle therapy to help restart natural testosterone production after stopping anabolic steroids, since steroid use suppresses the HPG axis. This history is part of why WADA bans the whole SERM/anti-estrogen class, since it's closely tied to managing steroid use even when someone uses it independently.

Can enclomiphene cause a positive test for steroids?

No, enclomiphene itself isn't an anabolic steroid and won't trigger a steroid-metabolite positive. But it will trigger its own violation under WADA's S4 anti-estrogen category, and it's frequently detected alongside actual steroid metabolites in athletes who use both, which is part of why anti-doping labs specifically screen for it.

Is enclomiphene legal to buy and use if I'm not a competitive athlete?

It's legal to obtain through a valid prescription from a licensed prescriber, filled by a licensed compounding pharmacy under Federal Food, Drug, and Cosmetic Act Section 503A rules ^[7]. It's not sold over the counter, and buying it without a prescription from an unregulated source carries real quality and legal risk.

Sources

1. World Anti-Doping Agency, 2025 Prohibited List: Enclomiphene/clomiphene-class anti-estrogens fall under Section S4, banned at all times, in and out of competition
2. FDA label information / clinical pharmacokinetic data on clomiphene isomers: Enclomiphene's elimination half-life and detection window considerations
3. World Anti-Doping Agency, International Standard for Therapeutic Use Exemptions: TUE requires a clear medical condition, no reasonable alternative, and no additional performance enhancement beyond return to normal health
4. World Anti-Doping Code 2021: Default four-year ineligibility period for non-specified substance violations absent proof of no intent
5. Endocrine Society Clinical Practice Guideline, Testosterone Therapy in Men with Hypogonadism: Exogenous testosterone suppresses the HPG axis, reducing LH, FSH, and spermatogenesis
6. Kim et al., clinical trial data on enclomiphene citrate (Androxal) in secondary hypogonadism: Enclomiphene raised serum testosterone while maintaining LH, FSH, and sperm parameters better than exogenous testosterone comparators
7. U.S. Food and Drug Administration, Federal Food, Drug, and Cosmetic Act Section 503A: Legal basis permitting licensed pharmacies to compound drugs like enclomiphene under an individual prescription